Trial intelligence / Profile preview

Esketamine to prevent trauma-related intrusive memories

NL-OMON56481Completed

Sponsor
Maastricht University
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Trial of esketamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Maastricht University. Primary endpoints: Number of self-reported intrusive memories over 7 days and Distress of self-reported intrusive memories over 7 days. Started Mar 2024; status: completed.

02

Drugs

esketamine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NL-OMON56481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON56481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call